1. Home
  2. NAMS vs NEA Comparison

NAMS vs NEA Comparison

Compare NAMS & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$34.87

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Logo Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01

NEA

Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01

HOLD

Current Price

$11.68

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAMS
NEA
Founded
2019
2002
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NAMS
NEA
Price
$34.87
$11.68
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$46.40
N/A
AVG Volume (30 Days)
978.9K
803.4K
Earning Date
11-05-2025
01-01-0001
Dividend Yield
N/A
4.23%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,243,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.91
N/A
52 Week Low
$14.06
$9.20
52 Week High
$42.00
$11.37

Technical Indicators

Market Signals
Indicator
NAMS
NEA
Relative Strength Index (RSI) 44.70 59.81
Support Level $33.91 $11.50
Resistance Level $36.00 $11.65
Average True Range (ATR) 1.50 0.09
MACD -0.04 0.01
Stochastic Oscillator 43.64 78.00

Price Performance

Historical Comparison
NAMS
NEA

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01

Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.

Share on Social Networks: